The Case for and Against Abbott Laboratories (ABT)

Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $60.77, up from yesterday’s close by 0.38%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Abbott Laboratories (ABT) currently trades with a market capitalization of $106.55 Billion. That value represents a market adjusting for revenues that have been growing by 16.65 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $4.97 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.71 on a per share basis this quarter. Perhaps, that suggests something about why 0.81% of the outstanding share supply is held by institutional investors.

Technical Analysis

As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Abbott Laboratories recorded a 52-week high of $64.60. It is now trading 3.83% off that level. The stock is trading $60.09 its 50-day moving average by -0.68%. The stock carved out a 52-week low down at $42.88.

In recent action, Abbott Laboratories (ABT) has made a move of +2.10% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.61, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.84% with $1.74 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ABT.

Previous articleDrilling Down Into InnSuites Hospitality Trust (IHT)
Next articleJust the Facts on Geron Corporation (GERN)